Orange Stock Plummets to a One-Month Low, RSI Indicates Extreme Overselling
On Thursday, March 12, Orange's stock slightly increased by 0.64% to €17.1750, after hitting a one-month low of €16.8250 during the session. This technical configuration results from a 2.66% decline over seven days, partially erasing the strong performance recorded over the past year. Two signals converge today towards the same reading: the short-term selling pressure has reached an extreme level.
Significant RSI Drop Highlights Selling Pressure
The most notable signal of the session is the sharp drop in Orange's RSI, which fell to 28, below the technical threshold of 30 that defines the oversold zone. This movement is particularly striking as the indicator was at 54 the previous day and fluctuated between 50 and 70 over the last ten sessions, indicating a very rapid deterioration in short-term dynamics. This downward crossing coincides precisely with the recording of a monthly low at €16.8250, a level that also corresponds to the lower boundary of the Bollinger Bands, set at €16.78. The two signals reinforce each other: the pressure on the prices materializes an exit at the bottom of the volatility envelope, while the RSI confirms that this pressure is unusual compared to the previous weeks. However, the price remains above the 50-day moving average at €16.09, which constitutes a first structural reference level, and well above the 200-day MA at €14.23.
Morgan Stanley Updates Amid Accelerated Correction
In this context of accelerated correction, Morgan Stanley released an update on its follow-up of the stock on March 12. The American bank maintains its market-weight recommendation while raising its price target from €15.50 to €16.50, a level that remains below the current price. Regarding the schedule, investors will soon have a fundamental reference point: the publication of the first quarter 2026 results is scheduled for April 23. This deadline could be a catalyst for reassessing the operational trajectory of the group, in a context where the stock still shows an annual performance of nearly 46% over the past twelve months, reflecting a significant revaluation undertaken over the long period.
